BridgeBio Pharma
BBIO
BBIO
178 hedge funds and large institutions have $1.45B invested in BridgeBio Pharma in 2022 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 49 increasing their positions, 59 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
178
Holders Change
-17
Holders Change %
-8.72%
% of All Funds
2.82%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
43
Increased
49
Reduced
59
Closed
57
Calls
$10.2M
Puts
$4.17M
Net Calls
+$6M
Net Calls Change
-$43M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
$93.4M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$12.5M |
| 3 |
D.E. Shaw & Co
New York
|
$25.3M |
| 4 |
Morgan Stanley
New York
|
$11.7M |
| 5 |
LCM
Laurion Capital Management
New York
|
$7.06M |
